BMRN
BioMarin Pharmaceutical Inc (BMRN) BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Other Release
BioMarin Pharmaceutical Inc (BMRN) Q4 2025 Earnings Call Transcript
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q4 2025 Earnings Call dated Feb. 23, 2026 Corporate Participants: Tracey McCarty — Investor Relations…
BioMarin Pharmaceutical Inc (BMRN) Sec Form 10K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 10K
BioMarin Pharmaceutical Inc (BMRN) U.S. Food and Drug Administration Approves BioMarin’s PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Other Release
BioMarin Pharmaceutical Inc (BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (BMRN) Summit Meeting
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Summit Meeting
BioMarin Pharmaceutical Inc (BMRN) Barclays 28th Annual Global Healthcare Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (BMRN) Leerink 2026 Global Healthcare Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (BMRN) TD Cowen 46th Annual Health Care Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (BMRN) Q4 2025 Earnings Results
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q4 2025 Earnings Release